Finding Description
Based on observation, staff interview, and record review, the facility did not provide pharmaceutical services to ensure all drugs and biologicals were accurately acquired, received, dispensed, and administered for 2 residents (R) (R44 and R48) of 5 residents reviewed for medication administration.
R44's medication card labels for diltiazem (a blood pressure (BP) medication), carvedilol (a BP medication) and spironolactone (a BP medication) were not updated to reflect the orders in R44's Medication Administration Record (MAR).
During an observation of medication administration on 4/16/24, staff crushed R48's potassium chloride extended release (ER) medication.
Findings include:
The facility's Oral Medications policy, dated 3/2018, indicates: Procedure: 1) Read the specific instructions that come with the prescription or the medication, e.g. give with food, rush the medication, etc
The facility's Crushed Medication policy, updated 7/2023, indicates: Licensed nursing staff and medication technicians to assure that medications shall be crushed in accordance with standards of practice for safety and accuracy in medication administration taking into consideration the resident's preferences. Procedure: 5) Medications that typically should not be crushed include, but are not limited to: .c. Sustained-release or extended-release medications.
1. From 4/15/24 through 4/17/24, Surveyor reviewed R44's medical record. R44 was admitted to the facility with diagnoses including hypertensive chronic kidney disease (chronic high blood pressure causing kidney damage), Parkinson's disease, and bradycardia (slow heart rate). R44's Minimum Data Set (MDS) assessment, dated 2/15/24, contained a Brief Interview for Mental Status (BIMS) score of 15 out of 15 which indicated R44 had intact cognition.
On 4/16/24 at 8:25 AM, Surveyor observed Licensed Practical Nurse (LPN)-F administer R44's AM medications from pharmacy cards that contained the following orders:
~Diltiazem 24 hour ER 240 milligrams (mg) hold if systolic blood pressure (SBP) (measures the force the heart exerts on the walls of the arteries each time it beats) <90.
~Spironolactone 25 mg hold if SBP <90
~Carvedilol 3.125 mg hold if SBP <90.
On 4/16/24 at 8:32 AM, Surveyor asked LPN-F if LPN-F obtained R44's BP prior to administering R44's AM medication. LPN-F indicated LPN-F did not obtain R44's BP. When Surveyor asked if R44's BP should have been obtained prior to administering diltiazem, spironolactone and carvedilol, LPN-F indicated LPN-F did not realize the medication cards contained directions to hold the medications if R44's SBP was < 90. LPN-F reviewed the medication cards with Surveyor and confirmed the cards contained BP parameters. LPN-F indicated LPN-F thought R44 was removed from BP monitoring and stated LPN-F would clarify with LPN-F's supervisor (LPN-D).
On 4/16/24 at 8:35 AM, Surveyor interviewed LPN-D who indicated R44's BP parameters were initiated in October 2023, however, R44's provider was updated in January 2024 and changed the order to weekly BP/update provider with any issues. LPN-D stated the order was faxed to pharmacy to discontinue R44's BP parameters. LPN-D indicated the pharmacy did not update R44's diltiazem, spironolactone, and carvedilol medication cards. Surveyor requested a copy of the fax which was not provided.
On 4/16/24 at 9:23 AM, Surveyor interviewed Consultant Pharmacist (CP)-G via phone regarding BP parameters for R44's diltiazem, spironolactone, and carvedilol. CP-G indicated if a medication card contains BP parameters, CP-G expects staff to check a resident's BP prior to administration of the medication. CP-G confirmed R44's diltiazem, spironolactone, and carvedilol medication cards contained BP parameters. CP-G verified the pharmacy did not remove R44's BP parameters because the pharmacy did not receive an order to discontinue the BP parameters. CP-G indicated the pharmacy's medication cards reflect the most current order, therefore, directions on the cards should be followed. CP-G stated if the order on a card is not current, the facility should contact the pharmacy and clarify the order. CP-G stated if R44's BP parameters were discontinued in January, the facility should have updated the pharmacy. CP-G confirmed the pharmacy did not receive a fax from the facility to discontinue R44's BP parameters.
On 4/16/24 at 9:37 AM, Surveyor reviewed R44's medical record and noted a progress note, dated 1/12/24, that indicated:
~Order Note: Fax sent with request to decrease BP monitoring. Provider response: Thanks for update BPs are variable, but overall acceptably controlled, as are heart rates (HR). No reported symptoms related to BP/HR or meds. Check BP/HR once weekly per unit routine and update PRN (as needed) concerns.
On 4/16/24 at 9:44 AM, Surveyor reviewed R44's physician orders and noted the following:
~Carvedilol oral tablet, give 3.125 mg by mouth in the morning for hypertension and give 6.25 mg by mouth at bedtime for hypertension
~Diltiazem HCl ER oral capsule 24 hour, give 240 mg by mouth in the morning for hypertension
~Spironolactone oral tablet, give 25 mg by mouth in the morning for hypertension
2. From 4/15/24 through 4/17/24, Surveyor reviewed R48's medical record. R48 was admitted to the facility with diagnoses including Parkinsonism, hypokalemia (low potassium), and dementia. R48's MDS assessment, dated 3/17/24, contained a BIMS score of 14 out of 15 which indicated R48 had intact cognition.
On 4/16/24 at 8:12 AM, Surveyor observed LPN-F prepare R48's AM medications which included potassium chloride ER 20 milliequivalents (mEq). LPN-F crushed the potassium chloride ER with R48's other medications, except fluoxetine (an antidepressant medication).
On 4/16/24 at 8:14 AM, Surveyor asked LPN-F to clarify which medications were crushed prior to administration. LPN-F reviewed R48's MAR and confirmed R48's potassium chloride ER was crushed, but should not have been crushed.
On 4/16/24 at 10:33 AM, Surveyor reviewed R48's physician orders and noted the following:
~Potassium chloride ER oral tablet, give 20 mEq by mouth in the morning for low potassium prevention. May be broken in half and each half swallowed separately, or dissolve in 4 ounces (oz) of water.
-May crush medications unless contraindicated
On 4/16/24 at 1:11 PM, Surveyor interviewed Director of Nursing (DON)-B who indicated if a medication card does not coinicide with the order in a resident's medical record, staff should clarify the order with pharmacy. DON-B also indicated since R48's BP parameters were discontinued in January, staff should have already clarified the discrepancy with pharmacy.
On 4/17/24 at 8:27 AM, Surveyor interviewed DON-B regarding the facility's policy on ER medications, including potassium chloride ER. DON-B indicated if the directions state don't crush, staff should not crush the medication.